Details of the Drug Formulations

General Information of Drug (ID: DM5IKUF)

Drug Name
Dihydroergotamine Drug Info
Synonyms Migranal (TN)
Indication
Disease Entry ICD 11 Status REF
Cluster headache 8A81.0 Approved [1]
Migraine 8A80 Approved [2]
Migraine disorder Approved [1]
Therapeutic Class
Antimigraine Agents
Cross-matching ID
PubChem CID
10531
ChEBI ID
CHEBI:4562
CAS Number
511-12-6
TTD ID
D0V3ZA
VARIDT ID
DR00686
INTEDE ID
DR0504
ACDINA ID
D00199

Full List of Drug Formulations Containing This Drug

Dihydroergotamine 1 mg tablet
Company Formulation ID FDA Description
AvKARE; Carilion Materials Management; Mutual Pharmaceutical F05928 Stearic acid; Lactose; Mannitol; Butylated hydroxyanisole; Talc; Hydrogenated cottonseed oil; Povidone k90; Starch, corn
------------------------------------------------------------------------------------

References

1 Dihydroergotamine FDA Label
2 Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors. . The Journal of Headache and Pain 201314(Suppl 1):P75.